Rigshospitalet is the largest hospital in Denmark and the most highly specialised hospital in the country. The hospital's main building is a 16-storey functionalist highrise, one of the tallest structures in the central parts of the city.

There are 1,118 beds in Rigshospitalet, København, Børneonkologisk Afsnit 5002.

During the past decade, Rigshospitalet, København, Børneonkologisk Afsnit 5002 conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rigshospitalet, København, Børneonkologisk Afsnit 5002" are "Venous Thromboembolism" (2 trials) and "Secondary Prevention" (1 trials). Many other conditions were trialed in "Rigshospitalet, København, Børneonkologisk Afsnit 5002" in a lesser frequency.

Most popular intervention types in "Rigshospitalet, København, Børneonkologisk Afsnit 5002" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "dabigatran etexilate" (2 trials) and "standard of care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rigshospitalet, København, Børneonkologisk Afsnit 5002" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rigshospitalet, København, Børneonkologisk Afsnit 5002". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rigshospitalet, København, Børneonkologisk Afsnit 5002, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rigshospitalet, København, Børneonkologisk Afsnit 5002, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".